Credit Suisse Cuts Price Target on Molecular Partners to CHF6 From CHF8, Lowers Probability of Success for Ensovibep to 5%, Keeps Neutral Rating
Credit Suisse Cuts Price Target on Molecular Partners to CHF6 From CHF8, Lowers Probability of Success for Ensovibep to 5%, Keeps Neutral Rating
瑞士信貸將分子合作伙伴的目標價格從8瑞士法郎下調至6瑞士法郎，將Ensovibep的成功概率降至5％，維持中性評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間